What an uneducated, useless, nonsensical post.
EPT has met almost every promise made, aside from perhaps the 'fully funded to commercialisation' promise as they did again raise funds (very successfully) recently.
The 'hot air' you mention includes the peer reviewed study validating EPT's work in a highly medical journal specialising in the exact field (dementia) that EPT is involved with.
The recent rise to 9c was concurrent with the RAP US trial debacle. We are all well aware of that being the driving factor.
Likely the market is selling down EPT overall as I think a recent announcement flagged Q4 2018 (could be mistaken) as the children's software launch. Many are not willing to wait that long.
I've been freeing up funds for the potential drift downwards.
Hopefully the EPT share price will sink like a stone. If I can average down under 3c (yes I can dream) then I'll be a very happy boy.
The simple fact = Don't you forget about me Belfast child
EPT Price at posting:
4.8¢ Sentiment: Buy Disclosure: Held
